• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血源性白细胞介素-1受体拮抗剂可穿过血脑屏障。

Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier.

作者信息

Gutierrez E G, Banks W A, Kastin A J

机构信息

Veterans Affairs Medical Center, New Orleans, LA 70146.

出版信息

J Neuroimmunol. 1994 Dec;55(2):153-60. doi: 10.1016/0165-5728(94)90005-1.

DOI:10.1016/0165-5728(94)90005-1
PMID:7829665
Abstract

Recent work has shown that interleukin-1 alpha (IL-1 alpha) and IL-1 beta are transported from blood to brain across the blood-brain barrier by a saturable system. Here, we show that the endogenous IL-1 receptor antagonist (IL-1ra) radioactively labeled with either 125I or 35S is also transported across the blood-brain barrier by a saturable transport system. Between 0.33 and 0.65% of an intravenous dose of labeled IL-1ra entered each gram of brain. The three cytokines inhibited each other's transport in a way suggesting that their elevated blood levels would tend to favor the entry of IL-1 beta at the expense of IL-1 alpha. High performance liquid chromatography confirmed that radioactivity entering the brain represented intact cytokine. Recovery of radioactivity from cerebrospinal fluid, an area without blood vessels, and from the parenchymal fraction of the cortex, and area without circumventricular organs, after capillary depletion confirmed that blood-borne IL-1ra gained entry into the brain. The transport system for IL-1ra appeared to be linked to that for IL-1 alpha and IL-1 beta, but was not affected by IL-2, IL-6, TNF alpha, or MIP-1 alpha. The results show that IL-1ra circulating in the blood can cross the blood-brain barrier to enter the central nervous system.

摘要

最近的研究表明,白细胞介素-1α(IL-1α)和白细胞介素-1β(IL-1β)可通过一个可饱和系统从血液穿过血脑屏障运输至脑内。在此,我们发现,用125I或35S放射性标记的内源性白细胞介素-1受体拮抗剂(IL-1ra)同样可通过一个可饱和转运系统穿过血脑屏障。静脉注射剂量的标记IL-1ra中有0.33%至0.65%进入每克脑组织。这三种细胞因子相互抑制对方的运输,这表明它们血液水平的升高往往会有利于IL-1β的进入,而以IL-1α为代价。高效液相色谱法证实进入脑内的放射性代表完整的细胞因子。在毛细血管耗竭后,从无血管区域的脑脊液以及无室周器官区域的皮质实质部分回收放射性,证实血源性IL-1ra进入了脑内。IL-1ra的转运系统似乎与IL-1α和IL-1β的转运系统相关,但不受IL-2、IL-6、肿瘤坏死因子α或巨噬细胞炎性蛋白-1α的影响。结果表明,血液中循环的IL-1ra可穿过血脑屏障进入中枢神经系统。

相似文献

1
Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier.血源性白细胞介素-1受体拮抗剂可穿过血脑屏障。
J Neuroimmunol. 1994 Dec;55(2):153-60. doi: 10.1016/0165-5728(94)90005-1.
2
Interleukin-1 alpha in blood has direct access to cortical brain cells.血液中的白细胞介素-1α可直接作用于大脑皮质细胞。
Neurosci Lett. 1993 Nov 26;163(1):41-4. doi: 10.1016/0304-3940(93)90224-9.
3
Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice.血液中的白细胞介素-1α可穿过小鼠的内皮血脊髓屏障。
J Physiol. 1994 Sep 1;479 ( Pt 2)(Pt 2):257-64. doi: 10.1113/jphysiol.1994.sp020293.
4
Interleukin-2 does not cross the blood-brain barrier by a saturable transport system.白细胞介素-2不能通过可饱和转运系统穿过血脑屏障。
Brain Res Bull. 1994;34(2):103-9. doi: 10.1016/0361-9230(94)90005-1.
5
Selective transport of blood-borne interleukin-1 alpha into the posterior division of the septum of the mouse brain.血源性白细胞介素-1α向小鼠脑隔后部的选择性转运。
Brain Res. 1995 Nov 27;700(1-2):83-8. doi: 10.1016/0006-8993(95)00913-b.
6
Passage of cytokines across the blood-brain barrier.
Neuroimmunomodulation. 1995 Jul-Aug;2(4):241-8. doi: 10.1159/000097202.
7
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.小鼠肿瘤坏死因子α在小鼠体内从血液转运至大脑。
J Neuroimmunol. 1993 Sep;47(2):169-76. doi: 10.1016/0165-5728(93)90027-v.
8
Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier.白细胞介素-1α穿越血脑屏障过程中可饱和转运与细胞外途径的比较。
J Neuroimmunol. 1996 Jun;67(1):41-7. doi: 10.1016/0165-5728(96)00036-7.
9
Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.在过表达细胞内前体白细胞介素-1α的人皮肤成纤维细胞中,细胞内白细胞介素-1受体拮抗剂水平升高。
J Immunol. 1999 Oct 1;163(7):3969-75.
10
Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.细胞因子诱导单核吞噬细胞释放白细胞介素-1受体拮抗剂
Am J Respir Cell Mol Biol. 1994 May;10(5):521-5. doi: 10.1165/ajrcmb.10.5.8179914.

引用本文的文献

1
Targeting cytokine networks in neuroinflammatory diseases.靶向神经炎症性疾病中的细胞因子网络。
Nat Rev Drug Discov. 2024 Nov;23(11):862-879. doi: 10.1038/s41573-024-01026-y. Epub 2024 Sep 11.
2
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas.嵌合抗原受体T细胞疗法治疗侵袭性B细胞淋巴瘤。
Front Oncol. 2024 Jul 1;14:1394057. doi: 10.3389/fonc.2024.1394057. eCollection 2024.
3
Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications.细胞因子与朊病毒疾病发病机制之间的相互作用:见解与启示
Brain Sci. 2024 Apr 23;14(5):413. doi: 10.3390/brainsci14050413.
4
Comprehensive risk factor predictions for 3-year survival among HIV-associated and disseminated cryptococcosis involving lungs and central nervous system.HIV 相关肺和中枢神经系统播散性隐球菌病 3 年生存率的综合危险因素预测。
Infection. 2024 Oct;52(5):1875-1887. doi: 10.1007/s15010-024-02237-6. Epub 2024 Apr 13.
5
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies.与嵌合抗原受体(CAR)-T细胞疗法相关的不良事件全谱。
J Biomed Sci. 2023 Oct 21;30(1):89. doi: 10.1186/s12929-023-00982-8.
6
Anakinra in cerebral haemorrhage to target secondary injury resulting from neuroinflammation (ACTION): Study protocol of a phase II randomised clinical trial.阿那白滞素治疗脑出血以靶向神经炎症引起的继发性损伤(ACTION):一项 II 期随机临床试验研究方案。
Eur Stroke J. 2024 Mar;9(1):265-273. doi: 10.1177/23969873231200686. Epub 2023 Sep 15.
7
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.CD19 CAR T 细胞疗法和预防性阿那白滞素治疗复发或难治性淋巴瘤:2 期试验中期结果。
Nat Med. 2023 Jul;29(7):1710-1717. doi: 10.1038/s41591-023-02404-6. Epub 2023 Jul 3.
8
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody.年龄、剂量和与血细胞膜上 TfR 的结合会影响 TfR 转运的抗体向脑部的递送。
Fluids Barriers CNS. 2023 May 11;20(1):34. doi: 10.1186/s12987-023-00435-2.
9
Novel pathophysiological insights into CAR-T cell associated neurotoxicity.嵌合抗原受体T细胞相关神经毒性的新型病理生理学见解。
Front Neurol. 2023 Mar 8;14:1108297. doi: 10.3389/fneur.2023.1108297. eCollection 2023.
10
Safety evaluation of axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma.axi-cel 治疗复发或难治性大 B 细胞淋巴瘤的安全性评价。
Expert Opin Drug Saf. 2023 Jan;22(1):5-15. doi: 10.1080/14740338.2023.2177268. Epub 2023 Feb 17.